In This Section
Position Statements
- ASNC-SNMMI Joint Position Statment on the Clinical Indications for Myocardial Perfusion PET
- Radiopharmaceutical Reimbursement Policy Statement
- Dose Optimization Policy Statement
- FDA Radiation Reduction Program Policy Statement
- Use of Compounded Radiopharmaceuticals and Adjunct Drug Preparations Policy Statement
- Joint Statement on Radioactive Precautions Following Radioactive Iodine Therapy Policy Statement
- Beyond-Use Dates (BUD) for Tc-99m Policy Statement
- Domestic Isotope Availability Policy Statement
- Conditions of Participation/Direct Supervision Policy Statement
- Nuclear Medicine Research Funding Policy Statement